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Research Round Up- Managing Diabetes Care in the COVID-19 Pandemic 
Introduction 
The last research round up provided you with an overview of recent research around remote 
healthcare in COVID-19 with a focus on remote consultation and prescribing.  This month we will 
continue the theme of prescribing and care management during the COVID-19 global pandemic with 
a focus of prescribing for diabetes. As we are in the grip of a second wave of the pandemic and have 
seen increasing pressure on the NHS it is important to keep abreast of management of chronic long-
term conditions such as diabetes so that disease progression and complications can be monitored. 
Many of you are involved in managing long term conditions and although the research presented 
here is centred on diabetes, many of the issues and points are transferable to other chronic long-
term conditions.  
 
Effect of remote management on comprehensive management of diabetes mellitus during the 
COVID-19 epidemic 
This piece of original research, carried out in May 2020 in China used a questionnaire method to 
gather information about diabetic patients as a measure to determine recruitment before  
conducting a randomized controlled study to confirm the effectiveness of remote management 
using the mobile phone WeChat app on comprehensive management of diabetes mellitus during the 
COVID-19 epidemic. 540 valid questionnaires were completed. The results of the questionnaire 
survey showed that the management of diabetes during the epidemic was difficult and lead to a 
single centre trial being recruited to. 
The researchers assigned 90 cases to the intervention group (use of WeChat) and 90 cases to the 
control group. The intervention group was managed remotely through the WeChat app, and the 
control group received traditional medical treatment. The blood glucose, blood pressure, body mass 
index (BMI), time in range (TIR) and incidence of hypoglycaemia were compared after three months 
of follow-up. Due to some drop outs and exclusions, 80 people from each group had their data 
analysed. The demographics of the groups were as follows, the percentage of males was 63.3% and 
that of females was 36.7%. The majority of patients were 40–60 years old, accounting for 53.3%. 
Patients with T2DM were the most, accounting for 90.6%. The duration of diabetes was 1–5 years in 
45.6% of patients.  
The results outlined by the researchers showed that BMI and postprandial blood glucose (PBG) of 
the control group at 3 months was significantly higher than that at baseline (P < 0.001), and TIR 
decreased at 3 months (P < 0.05). There was no significant difference in blood pressure compared 
with baseline in the control group, while blood pressure decreased in the intervention group (P < 
0.05). In the intervention group, fasting blood glucose (FBG) and PBG decreased compared with their 
baseline values, and the TIR level increased, both of which were statistically significant (P < 0.001). 
The FBG, PBG, and TIR of the intervention group were better than those in the control group at 3 
months (P < 0.05). There was no difference in the incidence of hypoglycaemia between the two 
groups. The researchers conclude from these results that remote management can increase TIR 
without increasing the risk of hypoglycaemia. Remote management can prevent weight gain and 
improve patients’ self-management and compliance during the COVID-19 epidemic. They 
recommend that through the supervision and encouragement of doctors, patients can avoid weight 
gain and improve self-management ability and compliance during the COVID-19 epidemic.  
https://www.sciencedirect.com/science/article/pii/S1751991820303636 
 
Inpatient diabetes care during the COVID‐19 pandemic: A Diabetes UK rapid review of healthcare 
professionals' experiences using semi‐structured interviews 
This article published in October 2020 in the Journal of Diabetic Medicines, is a rapid review 
conducted by Diabetes UK consisted of a series of semi structured interviews of 28 healthcare staff. 
These healthcare professionals interviewed were made up of diabetes consultants, diabetes 
specialist nurses and any allied health professionals that were involved in delivery of diabetes 
inpatient care. The aim of the study was to review inpatient care for people with diabetes with a 
view to improvement. The COVID‐19 pandemic has impacted the way care is delivered across the 
UK. Diabetes UK sought to understand how inpatient care for people with diabetes has been 
affected and to identify opportunities, areas of concerns and recommendations for future practice. 
The authors found that although there was disruption to inpatient diabetes services this, for the 
most part, created positive environments and opportunities for new ways of working (in 93% of 
trusts included), but in the minority (the remaining 7%), impacted on the quality of care clinicians 
felt they were able to deliver. Regardless of location, the way hospitals re‐organised and prioritised 
inpatient services frequently determined whether clinicians reported a positive or negative 
experience. Services already delivering care congruent with Diabetes UK's recommendations, eg. 
employing strong clinical leadership and better systems and technology, described more positive 
experiences and felt they were able to provide a high standard of care despite the disruptions. 
They were able to elucidate the following common themes. 
• Use of technology 
• Service structure 
• Relationships with others 
• Recognition and importance 
• Momentum and opportunity 
Some case studies are also presented in the paper. 
The authors conclude and make recommendations for future practice. They emphasise that 
preparedness in the short term is important and identify areas of practice, including the following 
important points.  Maintaining or reinstating multidisciplinary diabetes inpatient teams. Evidencing 
the impact of enhanced services employed during the first peak of the pandemic to learn for the 
future. Maintaining technological advances or putting new systems in place where they have 
previously been unable to. Putting in place better processes to tackle key challenges such as 
discharge and patient education. Prioritising the well‐being of healthcare professionals to ensure 
there is time for rest and recovery. They also hint at the use of technology-based care forming part 





Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown 
This open access article published in the Journal of Nutrition and Diabetes in January 2021 sought to 
determine the effectiveness of telemedicine in diabetes care after the national lockdown imposed in 
March 2020 by the Italian government. The research team retrospectively analysed data from 
continuous or flash glucose monitoring systems shared through different cloud/online/internet-
based systems during the lockdown by subjects with type 1 diabetes and compared the data 
obtained 4 weeks before and 4 weeks after structured telephonic visit. Variables considered were 
mean glucose, time spent in target (70–180 mg/dl), hypoglycaemia (<70 mg/dl) and hyperglycaemia 
(>180 mg/dl), coefficient of variation, and length of sensor use. 71 participants were enrolled in the 
study  
They found that in the 4 weeks following the telephonic visit there was an improvement of 
glycaemic control, which showed a significant reduction of mean glucose, an increase of the time 
spent in target and a reduction of time spent in hyperglycaemia No changes were observed 
regarding glucose variability, time spent in hypoglycaemia, and length of sensor use. Similar results 
were observed in subjects treated with multiple daily injections or continuous subcutaneous insulin 
infusion. They conclude that the use of telephonic review, pared with remote parameter 
measurement was an effective way to replace routine clinic visits and recommend this could be 
integrated into future care opening up new means of review for patients with diabetes.  
https://www.nature.com/articles/s41387-020-00147-8 
Conclusion 
The NHS is still functioning in management, review and treatment of long-term chronic conditions 
despite the COVID-19 pandemic, but what is clear is that methods of consultation and monitoring 
have had to change due to the current situation. This is seen to be the case globally and not just a UK 
phenomenon.  Suggestions are that we may not need to resort to the traditional, full face to face 
management in the future as overall, remote management has shown no decrease in satisfaction 
with care or in the achievement of positive outcomes despite the lack of patient attendance or 
changes to inpatient service delivery brought about by the COVID-19 pandemic.  
